Virtus ETF Advisers LLC Point Biopharma Global Inc. Transaction History

Virtus ETF Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$6.67 - $9.71 $6,569 - $9,564	-985 Reduced 9.0%	9,954 $66,000
Q2 2023 Aug 14, 2023	SELL	$6.86 - $10.86 $27,186 - $43,038	-3,963 Reduced 26.59%	10,939 $99,000
Q1 2023 May 15, 2023	SELL	$6.78 - $8.1 $38,829 - $46,388	-5,727 Reduced 27.76%	14,902 $108,000
Q4 2022 Feb 14, 2023	BUY	$5.72 - $9.78 $31,425 - $53,731	5,494 Added 36.3%	20,629 $150,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $767 - $1,092	106 Added 0.71%	15,135 $117,000
Q2 2022 Aug 12, 2022	BUY	$5.6 - $9.5 $84,162 - $142,775	15,029 New	15,029 $102,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.